The United Kingdom-based 2018 Aesthetic Award results are in, and Bellus Medical came home with the prize! During a December evening of glitz, glamour, and celebration, the Barry Knapp Award for Product Innovation of the Year, supported by Medical Aesthetic Group, was presented to Bellus for our SkinPen® Precision microneedling device.

The Medical Aesthetics Group presented awards for products launched in the U.K. that showcase genuine innovation or product advancement leading to treatment for new indications, quicker or easier treatments, better treatment outcomes, enhanced patient safety — all backed up by sound evidence. Both the nominations and winner selection for this award were selected by an expert panel of judges appointed by Aesthetics.        

The U.K. award follows Bellus’ recent personal best of eight Aesthetics Everything Award wins and SkinPen’s  U.S. Food and Drug Administration (FDA) clearance. After a rigorous evaluation process to meet more than 90 validated requirements for the microneedling device, charger base, and proprietary cartridge, these awards confirm that SkinPen has set a new standard as the premier FDA-cleared microneedling device.   

“Bellus Medical, in partnership with BioActiveAesthetics, is honored to have received this prestigious award,” said Bellus President Joe Proctor. “SkinPen is a first-in-class technology that delivers safe and effective results. We are thankful to Medical Aesthetics Group for recognizing our innovation in aesthetics.” 

For more information about the award, view our press release. And feel free to share on social media using hashtags #SkinPen, #microneedling, #AestheticsAwards2018 and tagging Bellus Medical.